Follow
Ji Wen
Ji Wen
Principal Computational Biologist, Pfizer Inc.
Verified email at pfizer.com
Title
Cited by
Cited by
Year
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia
KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ...
New England journal of medicine 371 (11), 1005-1015, 2014
14772014
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology
I Qaddoumi, W Orisme, J Wen, T Santiago, K Gupta, JD Dalton, B Tang, ...
Acta neuropathologica 131, 833-845, 2016
3612016
Deregulation of DUX4 and ERG in acute lymphoblastic leukemia
J Zhang, K McCastlain, H Yoshihara, B Xu, Y Chang, ML Churchman, ...
Nature genetics 48 (12), 1481-1489, 2016
2882016
Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas
KW Pajtler, J Wen, M Sill, T Lin, W Orisme, B Tang, JM Hübner, ...
Acta neuropathologica 136, 211-226, 2018
2302018
Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes
M Clarke, A Mackay, B Ismer, JC Pickles, RG Tatevossian, S Newman, ...
Cancer discovery 10 (7), 942-963, 2020
2092020
Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia
E Waanders, Z Gu, SM Dobson, Ž Antić, JC Crawford, X Ma, ...
Blood cancer discovery 1 (1), 96-111, 2020
1202020
Genomic subtyping and therapeutic targeting of acute erythroleukemia
I Iacobucci, J Wen, M Meggendorfer, JK Choi, L Shi, SB Pounds, ...
Nature genetics 51 (4), 694-704, 2019
1202019
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome
YH Park, S Lal, JE Lee, YL Choi, J Wen, S Ram, Y Ding, SH Lee, E Powell, ...
Nature communications 11 (1), 6175, 2020
1112020
Structure and evolution of double minutes in diagnosis and relapse brain tumors
K Xu, L Ding, TC Chang, Y Shao, J Chiang, H Mulder, S Wang, TI Shaw, ...
Acta neuropathologica 137, 123-137, 2019
712019
Baseline frequency of inflammatory Cxcl9-expressing tumor-associated macrophages predicts response to avelumab treatment
Y Qu, J Wen, G Thomas, W Yang, W Prior, W He, P Sundar, X Wang, ...
Cell reports 32 (1), 2020
702020
Applications of single-cell RNA sequencing in drug discovery and development
B Van de Sande, JS Lee, E Mutasa-Gottgens, B Naughton, W Bacon, ...
Nature Reviews Drug Discovery 22 (6), 496-520, 2023
632023
Septal dysembryoplastic neuroepithelial tumor: a comprehensive clinical, imaging, histopathologic, and molecular analysis
JCH Chiang, JH Harreld, R Tanaka, X Li, J Wen, C Zhang, DR Boué, ...
Neuro-oncology 21 (6), 800-808, 2019
532019
A comprehensive collection of systems biology data characterizing the host response to viral infection
BD Aevermann, BE Pickett, S Kumar, EB Klem, S Agnihothram, ...
Scientific data 1 (1), 1-21, 2014
452014
Custom gene capture and next-generation sequencing to resolve discordant ALK status by FISH and IHC in lung adenocarcinoma
JS Jang, X Wang, PT Vedell, J Wen, J Zhang, DW Ellison, JM Evans, ...
Journal of Thoracic Oncology 11 (11), 1891-1900, 2016
412016
St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia
J Zhang, K McCastlain, H Yoshihara, B Xu, Y Chang, ML Churchman, ...
Nat Genet 48 (12), 1481-1489, 2016
412016
MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children’s Oncology Group Study
K Matlawska-Wasowska, H Kang, M Devidas, J Wen, RC Harvey, ...
Leukemia 30 (9), 1909-1912, 2016
362016
Genome-wide analysis of alternative transcripts in human breast cancer
J Wen, KH Toomer, Z Chen, X Cai
Breast cancer research and treatment 151, 295-307, 2015
352015
Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas
K Fukuoka, Y Mamatjan, R Tatevossian, M Zapotocky, S Ryall, ...
Neuro-oncology 22 (10), 1474-1483, 2020
332020
Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes. Cancer Discov; 2020
M Clarke, A Mackay, B Ismer, JC Pickles, RG Tatevossian, S Newman, ...
CD-19-1030.[Europe PMC free article][Abstract][CrossRef][Google Scholar] 10 …, 2020
302020
Computational identification of tissue-specific alternative splicing elements in mouse genes from RNA-Seq
J Wen, A Chiba, X Cai
Nucleic Acids Research 38 (22), 7895-7907, 2010
232010
The system can't perform the operation now. Try again later.
Articles 1–20